CYCN
Cyclerion Therapeutics Inc

7,590
Loading...
Loading...
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
1

Frequently Asked Questions

What is Market Cap of Cyclerion Therapeutics Inc?
What is the 52-week high for Cyclerion Therapeutics Inc?
What is the 52-week low for Cyclerion Therapeutics Inc?
What is Cyclerion Therapeutics Inc stock price today?
What was Cyclerion Therapeutics Inc stock price yesterday?
What is the PE ratio of Cyclerion Therapeutics Inc?
What is the Price-to-Book ratio of Cyclerion Therapeutics Inc?
What is the 50-day moving average of Cyclerion Therapeutics Inc?
How many employess does Cyclerion Therapeutics Inc has?

Latest CYCN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.